Shabnam Kharazi
1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
- FLT3-ITDs Instruct a Myeloid Differentiation and Transformation Bias in Lymphomyeloid Multipotent Progenitors
- Lymphomyeloid Contribution of an Immune-Restricted Progenitor Emerging Prior to Definitive Hematopoietic Stem Cells.
- 2012
- Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
- 2011
- Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation
- 2010
- Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development.
- Role of Biallelic C/EBPalpha Mutations and FLT-3 LTD in Initiation and Maintenance of AML
- FLT3 receptor in normal and malignant hematopoiesis
- 2009
- DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction
- 2008
- FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B Lymphopoiesis.
- Downregulation of Mpl marks the transition to lymphoid-primed multipotent progenitors with gradual loss of granulocyte-monocyte potential.